External News
- AACR
Benefits of Pre-surgical Immunotherapy Were Independent of Race in Patients with Aggressive Breast Cancer
- Healio
Neoadjuvant Immunotherapy Effective Regardless of Race in Triple-negative Breast Cancer
- Channel 3 News
Yale New Haven Gets New Mobile Mammography Unit
- Medpage Today
HER2-Targeted Therapy Improves Outcomes for Breast Cancer Patients
- OncLive
Hormone Therapies, ADCs Elicit Long-Term Survival Benefits Across Breast Cancer Subtypes
- Targeted Oncology
Efficacy of Neoadjuvant/Adjuvant Pembrolizumab in TNBC
- New York Times
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
- Fierce Biotech
ASCO: HER2 Diagnostics Need a Revolution as AstraZeneca, Daiichi’s Enhertu Looks to Redefine Breast Cancer
- Medicine Matters
DESTINY-Breast04 ‘Practice Changing’ for HER2-low Metastatic Breast Cancer
- Cure Today
Early Study Findings Show Novel Drug Elicits Promising Results in Metastatic Breast Cancers
